MedTrace Logo

Expand New Drugs for TB [endTB]

NCT03259269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2804

Last updated 2022-06-13

No results posted yet for this study

Summary

This observational study will examine the safety and efficacy of bedaquiline and delamanid used (individually, not together) in routine, multidrug regimens for treatment of MDR-TB. The information gathered in this study will inform doctors how best to use these TB drugs in the future.

Conditions

  • Tuberculosis, Multidrug-Resistant

Interventions

OTHER

This is a non-intervention observational study

No applicable intervention; this is a secondary data analysis observational study.

Sponsors & Collaborators

  • Médecins Sans Frontières, France

    collaborator OTHER

  • Interactive Research and Development

    collaborator OTHER

  • Harvard Medical School (HMS and HSDM)

    collaborator OTHER

  • Epicentre

    collaborator OTHER

  • Partners in Health

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-01
Primary Completion
2019-09-30
Completion
2019-12-30

Countries

  • Armenia
  • Bangladesh
  • Belarus
  • Burma
  • Ethiopia
  • Georgia
  • Indonesia
  • Kazakhstan
  • Kenya
  • Kyrgyzstan
  • Lesotho
  • Pakistan
  • Peru
  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03259269 on ClinicalTrials.gov